HQYHealthEquity

Median target
$113
calls from the last 12 months
Implied return
+19.6%
median target vs. price
Coverage
12 analysts · 12 calls
updated in the last 12 months
Consensus
11/0/1+10 net
Buy / Hold / Sell

Which analysts are behind HQY's consensus?

See every current rating, price target and the analysts' track records for HealthEquity — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 12 analysts with calls on HQY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

HQY elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-25InsidersDillon Adrian TDirectorInsider sale6.3K sh @ $104.47 · planned trade$658K
2026-08-25InsidersDillon Adrian TDirectorInsider sale1.3K sh @ $105.26 · planned trade$140K
2026-06-30CongressGilbert CisnerosCA-CA39Purchasesince trade +5.3%, vs market +3.3%$1K–$15K
2025-06-16CongressGilbert CisnerosCA-CA39Salesince trade -5.9%, vs market +33.7%$1K–$15K
2025-06-11CongressLisa McClainMI-MI09Purchasesince trade -9.0%, vs market -37.1%$1K–$15K
2025-01-29ExecutiveTrump, Donald JPresidentPurchaseHEALTHEQUITY INC$15,001 - $500,001
2024-06-21CongressJosh GottheimerNJ-NJ05Salesince trade +13.7%, vs market +29.1%$1K–$15K
2024-01-19CongressBlake MooreUT-UT01Salesince trade +30.0%, vs market +32.2%$1K–$15K
2024-01-19CongressBlake MooreUT-UT01Salesince trade +30.0%, vs market +32.2%$1K–$15K
2023-04-10CongressDaniel GoldmanNY-NY10Salesince trade +65.1%, vs market +28.1%$15K–$50K

More: congressional trades on HQY · insider activity · executive branch · trending